Skip to main content

Table 3 Cycle characteristics of patients who underwent insemination

From: Effects of SARS-CoV-2 infection on embryological outcomes in assisted reproductive technology during the Omicron epidemic

 

IVF

ICSI

COVID-19 (n = 13)

Non COVID-19 (n = 64)

P value

COVID-19 (n = 10)

Non COVID-19 (n = 59)

P value

Age (years)

35.05 ± 5.26

33.22 ± 5.11

0.068

34.86 ± 5.37

33.35 ± 5.13

0.744

BMI (kg/m 2)

21.78 ± 2.86

21.66 ± 2.82

0.113

21.52 ± 2.89

21.62 ± 2.80

0.225

Infertility duration (years)

4.97 ± 4.24

4.32 ± 3.83

0.188

5.16 ± 4.25

4.39 ± 3.85

0.581

Type of infertility

  

0.464

  

0.522

Primary infertility

3 (23.08%)

23 (35.94%)

 

7 (70.00%)

35 (59.32%)

 

Secondary infertility

9 (69.23%)

41 (64.06%)

 

3 (30.00%)

24 (40.68%)

 

Reasons of infertility

  

0.699

  

0.000

Female factor

7 (53.85%)

34 (53.13)

 

1 (10.00%)

26 (44.07%)

 

Male factor

2 (15.38%)

6 (9.38%)

 

5 (50.00%)

18 (30.51%)

 

Multiple factors

2 (15.38%)

18 (28.13)

 

0

13 (22.03)

 

Unexplained infertility

2 (15.38%)

6 (9.38%)

 

4 (40.00%)

2 (3.39%)

 
  1. COVID-19, Coronavirus disease-2019; IVF, in-vitro fertilization; ICSI, intracytoplasmic sperm injection; BMI, Body Mass Index
Back to article page

Journal of Ovarian Research

ISSN: 1757-2215

Contact us